Condition: Metastatic Castration-Resistant Prostate Cancer · Sponsor: Kyntra Bio
The purpose of this study is to evaluate the safety, efficacy, tolerability, and pharmacokinetics (PK) of FG-3246, a cluster of differentiation 46 (CD46) targeting antibody-drug conjugate (ADC), in the treatment of participants with mCRPC who have progressed following treatment with one prior second-generation androgen receptor signaling inhibitor (ARSI) in any setting and no prior taxane therapy in the mCRPC setting.
This description comes directly from the study's public registry record.
Javier Moreno · 415-978-1466 · jmoreno@kyntrabio.com
Mairead Carney · 415-978-1337 · mcarney@kyntrabio.com
Always discuss trial participation with your own doctor first.
| Western Regional Medical Center - City of Hope Phoenix Goodyear | Goodyear, Arizona, United States | Recruiting |
| HonorHealth Research Institute | Scottsdale, Arizona, United States | Recruiting |
| The University of Arizona Cancer Center - North Campus | Tucson, Arizona, United States | Recruiting |
| VA Greater Los Angeles Healthcare System | Los Angeles, California, United States | Recruiting |
| UCLA Clark Urology Center | Los Angeles, California, United States | Recruiting |
| University of California San Francisco | San Francisco, California, United States | Recruiting |
| New Haven Hospital - Yale Cancer Center | New Haven, Connecticut, United States | Recruiting |
| Bioresearch Partner - Aventura | Aventura, Florida, United States | Recruiting |
| Bioresearch Partner - Hialeah | Hialeah, Florida, United States | Recruiting |
| Winship Cancer Institute, Emory University | Atlanta, Georgia, United States | Recruiting |
| East Jefferson General Hospital Metairie | New Orleans, Louisiana, United States | Recruiting |
| New Mexico Oncology Hematology Consultants, Ltd. | Albuquerque, New Mexico, United States | Recruiting |
+ 8 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06842498